Gen2 Isthmus-Dependent Atrial Flutter Ablation Study

NATerminatedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

January 31, 2009

Conditions
Atrial Flutter
Interventions
DEVICE

Cardiac Ablation (Gen2 Cardiac Ablation System)

Ablation of isthmus-dependent atrial flutter

Trial Locations (3)

Unknown

University of Alabama Birmingham, Birmingham

St. Barnabus Medical Center, West Orange

Doylestown Hospital, Doylestown

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT00606463 - Gen2 Isthmus-Dependent Atrial Flutter Ablation Study | Biotech Hunter | Biotech Hunter